UnitedHealth Group stock costs EUR 335.90, 16.15 percent below its 52-week high
Published on 10/13/2026 at 16:17 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSPrice and valuation at a glance
- UnitedHealth Group stock stood 16.15 percent below its 52-week high on October 13, 2026.
- UnitedHealth Group's P/E ratio was 24.21 versus Humana's 39.46 on October 13, 2026.
- UnitedHealth Group stock costs EUR 335.90 at Lang & Schwarz on October 13, 2026 at 4:06 p.m. CEST, plus 0.03 percent versus the Xetra close of October 12, 2026.
- UnitedHealth Group had a USD 341.8 billion market capitalization on October 13, 2026.
UnitedHealth Group (ISIN US91324P1021) was trading at EUR 335.90 at Lang & Schwarz on October 13, 2026 at 4:06 p.m. CEST, plus 0.03 percent versus the Xetra close of October 12, 2026 at EUR 335.80. The price was 16.15 percent below the 52-week high of EUR 400.60, giving investors a clear range marker for the current level.
P/E trails Humana's multiple
UnitedHealth Group had a market capitalization of USD 341.8 billion and a P/E ratio of 24.21 on October 13, 2026. Humana's P/E ratio was 39.46, while Elevance Health traded at a P/E ratio of 18.78 on the same date.
The valuation gap puts UnitedHealth between two large managed-care peers on the earnings multiple. Its 52-week range ran from EUR 222.70 to EUR 400.60 on the German listing, and the current price sat 50.83 percent above the low.
Range leaves room below the high
UnitedHealth Group's German-listed quote stood within that annual range at the latest Lang & Schwarz timestamp. The Xetra comparison is modest because EUR 335.90 was only EUR 0.10 above the October 12 close of EUR 335.80.
Third-quarter earnings reset expectations
According to UnitedHealth Group on October 13, 2026, adjusted earnings per share reached USD 4.69 in the third quarter of 2026, versus USD 2.92 a year earlier, while revenue was USD 112.7 billion versus USD 113.2 billion.
Comparison with peers
UnitedHealth Group: plus 0.03 percent, P/E 24.21, market capitalization USD 341.8 billion.
Humana (NYSE, USD): minus 3.81 percent, P/E 39.46, market capitalization USD 50.1 billion.
Elevance Health (NYSE, USD): plus 0.17 percent, P/E 18.78, market capitalization USD 91.7 billion.
Price stays below the yearly high
At Lang & Schwarz, UnitedHealth Group stock was trading at EUR 335.90 on October 13, 2026 at 4:06 p.m. CEST, plus 0.03 percent versus the Xetra close of October 12, 2026 at EUR 335.80. The 52-week high remained EUR 400.60, placing the latest quote 16.15 percent below that level.
The further course of trading is shown by the continuously updated real-time quote of UnitedHealth Group stock.
UnitedHealth Group market data
- Company: UnitedHealth Group, Inc.
- ISIN: US91324P1021
- Ticker: UNH
- Primary exchange: NYSE
- Price Lang & Schwarz (as of October 13, 2026, 4:06 p.m. CEST): EUR 335.90
- Change versus Xetra close (October 12, 2026): plus 0.03 percent
- Xetra close (October 12, 2026): EUR 335.80
- Market capitalization: USD 341.8 billion (as of October 13, 2026)
- 52-week range: EUR 222.70-EUR 400.60 (as of October 13, 2026)
- Sector / Industry: Health Care / Health Insurance
Market context: Market report S&P 500.
